BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10394843)

  • 21. Tinea pedis acquired in mosques?
    Veraldi S; Esposito L; Gorani A
    Mycoses; 2018 Nov; 61(11):794-795. PubMed ID: 29600810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens.
    Bergstresser PR; Elewski B; Hanifin J; Lesher J; Savin R; Shupack J; Stiller M; Tschen E; Zaias N; Birnbaum JE
    J Am Acad Dermatol; 1993 Apr; 28(4):648-51. PubMed ID: 8463471
    [No Abstract]   [Full Text] [Related]  

  • 23. Antifungal activity of the new agent latoconazole in two tinea models.
    Ohmi T; Konaka S; Uchida M; Yamaguchi H
    Arzneimittelforschung; 1991 Aug; 41(8):847-51. PubMed ID: 1781809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Case for diagnosis. Pigmented foot lesion].
    Fond L; Godard W; Perrot JL; Michel JL; Misery L; Montelimard N; Boucheron S; Cambazard F
    Ann Dermatol Venereol; 1999 Apr; 126(4):341-2. PubMed ID: 10421939
    [No Abstract]   [Full Text] [Related]  

  • 25. Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis.
    Uchida K; Tanaka T; Yamaguchi H
    Microbiol Immunol; 2003; 47(2):143-6. PubMed ID: 12680717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and treatment of tinea pedis. A review and update.
    Page JC; Abramson C; Lee WL; McCarthy DJ; McGinley KJ; Williams D
    J Am Podiatr Med Assoc; 1991 Jun; 81(6):304-16. PubMed ID: 1920096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Griseofulvin in the treatment of dermatomycoses and onychomycoses produced by dermatophytes of the Trichophyton group.
    Kubec K
    Mycopathol Mycol Appl; 1968 Jan; 34(1):90-3. PubMed ID: 4231313
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of long-term tinea pedis with miconazole. Double-blind clinical evaluation.
    Brugmans JP; Van Cutsem JM; Thienpont DC
    Arch Dermatol; 1970 Oct; 102(4):428-32. PubMed ID: 4919243
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis.
    Ablon G; Rosen T; Spedale J
    Int J Dermatol; 1996 Aug; 35(8):591-3. PubMed ID: 8854165
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis.
    Savin RC
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):807-9. PubMed ID: 2229529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hand mycosis caused by the yeast Candida parapsilosis concomitant with foot mycosis caused by the dermatophyte Trichophyton rubrum].
    Rieth H
    Mykosen; 1968 Feb; 11(2):169-70. PubMed ID: 5757996
    [No Abstract]   [Full Text] [Related]  

  • 32. Tinea pedis: the etiology and global epidemiology of a common fungal infection.
    Ilkit M; Durdu M
    Crit Rev Microbiol; 2015; 41(3):374-88. PubMed ID: 24495093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of ajoene, an organosulphur derived from garlic, in the short-term therapy of tinea pedis.
    Ledezma E; DeSousa L; Jorquera A; Sanchez J; Lander A; Rodriguez E; Jain MK; Apitz-Castro R
    Mycoses; 1996; 39(9-10):393-5. PubMed ID: 9009665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis.
    Shi TW; Zhang JA; Zhang XW; Yu HX; Tang YB; Yu JB
    Mycoses; 2014 Sep; 57(9):560-4. PubMed ID: 24697872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis.
    Kikuchi I; Tanuma H; Morimoto K; Kawana S
    Mycoses; 2008 Jan; 51(1):7-13. PubMed ID: 18076589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatments of tinea pedis.
    Gupta AK; Chow M; Daniel CR; Aly R
    Dermatol Clin; 2003 Jul; 21(3):431-62. PubMed ID: 12956197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic-type tinea pedis.
    Kikuchi I; Tanuma H; Morimoto K; Kawana S
    Mycoses; 2008 Nov; 51(6):523-31. PubMed ID: 18422915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
    Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
    Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of oral treatment with terbinafine in a guinea pig model of tinea pedis].
    Uchida K; Yamaguchi H
    Jpn J Antibiot; 1994 Oct; 47(10):1401-6. PubMed ID: 7807699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.